PML/RARA t(15:17) Quantitative
This test quantifies the PML-RARa fusion gene transcript in blood, which is indicative of acute promyelocytic leukemia (APL). It helps monitor treatment response and disease progression.
Overview of PML/RARA t(15:17) Quantitative in Palakkad
What does the PML-RARA t(15;17) test detect?
This test identifies a specific genetic translocation found in acute promyelocytic leukemia (APL), helping diagnose and monitor this subtype of leukemia.
Why is the test important?
It confirms the presence of the PML-RARA fusion gene, essential for accurate diagnosis and treatment planning in APL cases.
How is the test performed?
A bone marrow or blood sample is analyzed using molecular methods like RT-PCR to detect the PML-RARA transcript quantitatively.
Can it be used to track treatment response?
Yes, the quantitative nature of the test helps assess disease burden and monitor remission or relapse during therapy.
What does a negative result mean?
A negative result typically indicates the absence of the PML-RARA fusion gene, suggesting the leukemia may not be APL.
Test included
- Speciment Type
- Pml Raralpha Long Form
- Pml Raralpha Variant Form
- Pml Raralpha Short Form
Doctor information
Test code
9906
CPT and Loinc codes
Department
- Advanced Molecular Diagnostics R&d
Turn around time
2 Working Days
Test run frequency
Every Day TIME - 10:00
Performing locations
1 labs across India
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Bone Marrow | Others | 1 ML |
| Edta Whole Blood | Lavender Vacutainer | 3 ML |
| Others (fx) | Others | 3 ML |
Specimen stability information
Bone Marrow, Edta Whole Blood
Collection instructions
Clinical History
Package price
₹5700
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestPML/RARA t(15:17) Quantitative
₹5700